Allurion Technologies Inc.

ALUR ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024
Revenue $2.9M $3.6M $2.7M $3.4M $5.6M $5.6M $5.4M $11.8M
Cost of Revenue $1.7M $2.0M $1.4M $882.0K $1.4M $3.1M $2.3M $2.8M
Gross Profit $1.2M $1.6M $1.3M $2.5M $4.2M $2.5M $3.1M $9.0M
Gross Margin 41.7% 44.5% 49.1% 73.9% 74.6% 45.3% 58.0% 76.4%
Operating Expenses
Research & Development $912.0K $1.1M $2.0M $1.8M $2.6M $4.1M $3.2M $4.3M
SG&A Expense $2.7M $5.1M $5.8M $5.2M $5.2M $7.7M $7.0M $7.3M
Operating Income $-3.7M $-6.3M $-9.6M $-7.0M $-7.3M $-17.1M $-12.3M $-9.3M
Operating Margin -126.6% -174.2% -362.3% -205.7% -130.5% -306.2% -229.9% -79.4%
Interest Expense — — — — — — — $339.0K
Pretax Income $-6.1M $-6.1M $-11.9M $-9.3M $-1.4M $-9.1M $8.8M $-8.3M
Income Tax Expense $22.0K $-73.0K $9.0K $43.0K $95.0K $508.0K $69.0K $65.0K
Net Income $-6.1M $-6.0M $-11.9M $-9.3M $-1.5M $-9.6M $8.7M $-8.3M
Net Margin -206.8% -167.0% -447.1% -276.3% -26.9% -171.8% 162.8% -70.7%
EPS (Basic) $-0.46 $-0.69 $-0.51 $-0.43 $-0.10 $-1.10 $1.14 $-1.45
EPS (Diluted) $-0.46 $-0.69 $-0.51 $-0.43 $-0.10 $-1.07 $1.13 $-1.45
Shares Outstanding (Basic) 13.4M 7.5M 23.3M 21.9M 14.3M 6.7M 7.7M 5.8M
Shares Outstanding (Diluted) 13.4M 7.5M 23.3M 21.9M 14.3M 6.7M 7.7M 5.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →